Posted in M&A / Deals Otsuka grows in neuroplastogens with $1.225bn Transcend buy March 29, 2026 Pharmaphorum Otsuka has agreed to acquire Transcend Therapeutics and its MDMA-based neuroplastogen drug candidate for PTSD, heading for phase 3 trials. M&A / DealsNeuroscienceRead full story